Aardvark Therapeutics, Inc. (AARD)

Aardvark Therapeutics Statistics

Total Valuation

AARD has a market cap or net worth of $82.25 million. The enterprise value is -$27.34 million.

Market Cap	82.25M
Enterprise Value	-27.34M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, after market close.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

AARD has 21.82 million shares outstanding. The number of shares has increased by 391.06% in one year.

Current Share Class	21.82M
Shares Outstanding	21.82M
Shares Change (YoY)	+391.06%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	14.71%
Owned by Institutions (%)	25.76%
Float	11.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.77
P/TBV Ratio	0.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.61, with a Debt / Equity ratio of 0.00.

Current Ratio	10.61
Quick Ratio	10.43
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -64.44% and return on invested capital (ROIC) is -43.57%.

Return on Equity (ROE)	-64.44%
Return on Assets (ROA)	-40.27%
Return on Invested Capital (ROIC)	-43.57%
Return on Capital Employed (ROCE)	-58.82%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.44M
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.29% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-51.29%
50-Day Moving Average	9.48
200-Day Moving Average	11.47
Relative Strength Index (RSI)	23.75
Average Volume (20 Days)	379,769

Short Selling Information

The latest short interest is 1.38 million, so 6.34% of the outstanding shares have been sold short.

Short Interest	1.38M
Short Previous Month	1.81M
Short % of Shares Out	6.34%
Short % of Float	12.33%
Short Ratio (days to cover)	3.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-62.73M
Pretax Income	-57.59M
Net Income	-57.59M
EBITDA	-62.69M
EBIT	-62.73M
Earnings Per Share (EPS)	-$2.93

Balance Sheet

The company has $110.03 million in cash and $441,000 in debt, with a net cash position of $109.59 million or $5.02 per share.

Cash & Cash Equivalents	110.03M
Total Debt	441,000
Net Cash	109.59M
Net Cash Per Share	$5.02
Equity (Book Value)	106.63M
Book Value Per Share	4.89
Working Capital	101.34M

Cash Flow

In the last 12 months, operating cash flow was -$54.17 million and capital expenditures -$95,000, giving a free cash flow of -$54.27 million.

Operating Cash Flow	-54.17M
Capital Expenditures	-95,000
Depreciation & Amortization	36,000
Net Borrowing	n/a
Free Cash Flow	-54.27M
FCF Per Share	-$2.49

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AARD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-391.06%
Shareholder Yield	-391.06%
Earnings Yield	-70.02%
FCF Yield	-65.98%

Analyst Forecast

The average price target for AARD is $19.63, which is 420.69% higher than the current price. The consensus rating is "Buy".

Price Target	$19.63
Price Target Difference	420.69%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1